608O Preliminary safety and clinical activity of ASP3082, a first-in-class, KRAS G12D selective protein degrader in adults with advanced pancreatic (PC), colorectal (CRC), and non-small cell lung cancer (NSCLC)

Wungki Park, Anup Kasi, Alexander I. Spira, Jordan Berlin, J.S. Wang, Benjamin Herzberg, Yuko Kuboki, Shigehisa Kitano, M. Pelster, J.W. Goldman, D. Morgensztern, Soichiro Kondo, P.A. Jänne, Hisaki Fujii, Heon‐Jeong Lee, Stanley C. Gill, Abdel Saci, P. Lorusso, Anthony W. Tolcher